Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Dent Res ; 96(11): 1322-1329, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28662356

RESUMEN

Prior genome-wide association studies for oral clefts have focused on clinic-based samples with unclear generalizability. Prior samples were also small for investigating effects by cleft type and exclusively studied isolated clefts (those occurring without other birth defects). We estimated the effects of 17 top loci on cleft types in both isolated and nonisolated cases in the largest consortium to date of European-descent population-based studies. Our analytic approach focused on a mother-child dyad case-control design, but it also allowed analyzing mother-only or child-only genotypes to maximize power. Our total sample included 1,875 cases with isolated clefts, 459 cases with nonisolated clefts, and 3,749 controls. After correcting for multiple testing, we observed significant associations between fetal single-nucleotide polymorphisms (SNPs) at IRF6, PAX7, 8q21.3, 8q24, KIAA1598-VAX1, and MAFB and isolated cleft lip only (CLO) and cleft lip and palate (CLP). Significant associations were observed between isolated CLO and fetal SNPs near TPM1 and NOG1 and between CLP and fetal SNPs at ABCA4-ARHGAP29, THADA, FOXE1, and SPRY2. Overall, effects were similar for isolated CLO and CLP, except for ABCA4-ARHGAP29. A protective effect was observed for the fetal NOG1 SNP on cleft palate only, opposite in direction to the effect on CLO. For most fetal SNPs, a dose-response allelic effect was observed. No evidence of parent-of-origin or maternal genome effects was observed. Overall, effect direction and magnitude were similar between isolated and nonisolated clefts, suggesting that several loci are modifiers of cleft risk in both isolated and nonisolated forms. Our results provide reliable estimates of the effects of top loci on risks of oral clefts in a population of European descent.


Asunto(s)
Labio Leporino/genética , Fisura del Paladar/genética , Sitios Genéticos/genética , Alelos , Estudios de Casos y Controles , Labio Leporino/embriología , Fisura del Paladar/embriología , Femenino , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Genotipo , Humanos , Recién Nacido , Masculino , Polimorfismo de Nucleótido Simple , Población Blanca
2.
Biochim Biophys Acta ; 1408(1): 18-24, 1998 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-9784594

RESUMEN

Protoporphyria (PP) is caused by a deficiency of ferrochelatase (FC) activity, which catalyzes the final step in the heme biosynthesis pathway. Bovine are the only species other than man with naturally occurring PP. For expression of the PP phenotype, two copies of the mutated gene are necessary in bovine, whereas one copy is sufficient in humans. We report the first potential disease-causing mutation in the bovine FC gene. The coding region of FC was sequenced from the liver tissue of protoporphyric and normal bovine. A transversion was identified at nucleotide position 1250 which changed the stop codon to leucine (TGA-->TTA) in the protoporphyric FC sequence. As a consequence, the mutant protein is predicted to have an additional 27 amino acids. To screen other bovine for the G-->T transversion, cDNAs from liver tissue of clinically and biochemically normal, and from heterozygous and homozygous affected animals were used for allele-specific polymerase chain reaction. Three normal animals had only the G allele, five affected animals had only the T allele, and three heterozygous animals had both the G and T alleles. These results support our hypothesis that this mutation causes PP in bovine.


Asunto(s)
Enfermedades de los Bovinos/genética , Codón de Terminación , Ferroquelatasa/genética , Hígado/enzimología , Mutación Puntual , Porfiria Eritropoyética/genética , Porfiria Eritropoyética/veterinaria , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Bovinos , Enfermedades de los Bovinos/enzimología , Clonación Molecular , ADN Complementario , Ferroquelatasa/biosíntesis , Ferroquelatasa/química , Humanos , Datos de Secuencia Molecular , Porfiria Eritropoyética/enzimología , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química
5.
Nurs Times ; 63(8): 252-3, 1967 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-6018613
9.
12.
Nurs Times ; 66(25): 777-9, 1970 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-5424034
15.
Blood ; 87(7): 2993-9, 1996 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-8639921

RESUMEN

Congenital methemoglobinemia caused by an erythrocytic deficiency of cytochrome b5 reductase (b5R; type I) in African-American individuals was first reported by this laboratory. The rarity of this observation is possibly due to the difficulty detecting cyanosis that is masked by naturally occurring dark skin pigment. Since previous biochemical studies on the African-American family with variant enzyme b5R-Shreveport showed enzyme instability, we focused on molecular analysis of its transcript. The transcript size was the same as that of a normal control. The nucleotide sequence of both normal and variant transcripts were examined by directly sequencing reverse transcriptase-polymerase chain reaction (RT-PCR) product. The propositus was found to be homozygous for a G to A transition at codon 212 in exon 8, changing a glutamate to a lysine (E212K). In addition, a C to G transversion was found at codon 116 in exon 5, changing a threonine to a serine (T116S). Using allele-specific PCR, we determined that E212K was found only in the propositus and her heterozygous mother. Furthermore, E212K is predicted to disrupt an alpha-helix peptide structure of b5R, suggesting that this is likely the disease-causing mutation. In contrast, T116S was found to be a high-frequency polymorphism specific for the African-American population. The E212K mutation is uniquely present in the 3' end of the b5R gene (exon 8), which differs from those b5R mutations found among Japanese subjects (exons 3 and 5) and in an Italian subject (exon 4) and, thus, further contributes to our understanding of the structure/function relationship of this housekeeping enzyme.


Asunto(s)
Población Negra/genética , Reductasas del Citocromo/genética , Metahemoglobinemia/genética , Adolescente , Secuencia de Bases , Clonación Molecular , Citocromo-B(5) Reductasa , Femenino , Humanos , Masculino , Metahemoglobinemia/congénito , Metahemoglobinemia/enzimología , Metahemoglobinemia/etiología , Datos de Secuencia Molecular , Linaje , Mutación Puntual , Análisis de Secuencia
16.
Hum Genet ; 99(2): 248-50, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9048929

RESUMEN

NADH-cytochrome b5 reductase (b5R) is a member of a flavoenzyme family of dehydrogenases-electron transferases that participates in the transfer of electrons from the NADH generated in glycolysis to cytochrome b5. b5R is involved in the steady-state reduction of methemoglobin to hemoglobin in erythrocytes and is also involved in lipid metabolism in other cell types. In a search for mutations of the b5R gene in two unrelated African-American families, a high-frequency polymorphism was detected in the propositi from both families, as well as unrelated normal controls, consisting of a C-to-G transversion in exon 5 that changes threonine to serine at codon 116 (T116S). This is the first polymorphism found in the b5R gene. Using allele-specific PCR on the two propositi, their family members, and unselected populations of African-American, Caucasian, Asian, Indo-Aryan, and Arabic individuals, the C/G polymorphism was found in 26 of 112. African-American chromosomes (allele frequency = 0.23), but not in 108 Caucasian, 46 Asian, 44 Indo-Aryan, or 14 Arabic chromosomes. In preliminary studies, this polymorphism did not correlate with b5R enzyme activity or cause any disease phenotype. It remains to be determined whether this African-specific polymorphism that apparently originated recently in human evolution provides any special survival advantage.


Asunto(s)
Población Negra/genética , Negro o Afroamericano , Reductasas del Citocromo/genética , Polimorfismo Genético , Alelos , Citocromo-B(5) Reductasa , Humanos , Reacción en Cadena de la Polimerasa
17.
Eur J Pediatr ; 154(12): 983-90, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8801107

RESUMEN

UNLABELLED: In children with asthma, twice daily administration of salmeterol 25 micrograms, salmeterol 50 micrograms and salbutamol 200 micrograms were compared in two, 3-month, double-blind, parallel group studies, one using metered dose inhalers (MDIs), the other using dry powder inhalers (Diskhaler, DPIs). Both studies were continued for a further 9 months during which time exacerbation rates, lung function at the clinic and adverse events were monitored. Similarities in design and methodology of the two studies justified a combined analysis. Eight hundred and forty-seven asthmatic children aged between 4 and 16 (mean 10.1) years, requiring inhaled beta 2-agonist treatment were randomised to treatment. After a 2 week run-in when all bronchodilator therapy was withdrawn, 279 patients received salmeterol 25 micrograms bd, 290 patients salmeterol 50 micrograms bd and 278 patients salbutamol 200 micrograms bd. After 3 months' treatment the change from baseline in daily morning and evening peak expiratory flow (PEF) was significantly greater with salmeterol 50 micrograms bd than with salbutamol 200 micrograms bd (P < 0.001). Salmeterol 50 micrograms bd was also significantly better than salmeterol 25 micrograms bd at improving mean morning PEF (P = 0.017) but both treatments had a similar effect on evening PEF. Analysis of variance showed an interaction between baseline PEF less than 100% predicted normal value and treatment outcome. Analysis of this sub-set of patients with lower lung function revealed similar results to the total population although the improvements in PEF from baseline were greater. Data from both studies, showed that the improvement in lung function was maintained throughout 12 months' treatment. Patients receiving salmeterol 50 micrograms bd had significantly more symptom-free nights (P < 0.01) and a higher percentage of rescue bronchodilator-free days (P = 0.01). The incidence of asthma exacerbations was evenly distributed between the three treatment groups and there was no evidence of any change in the rate of occurrence of exacerbations over the 12 month period. Adverse events were no different across treatment groups or across age groups and were primarily related to the patients' disease state. CONCLUSION: Salmeterol 50 micrograms bd is the appropriate dose for the treatment of children with mild to moderate asthma.


Asunto(s)
Agonistas Adrenérgicos beta/uso terapéutico , Albuterol/análogos & derivados , Asma/tratamiento farmacológico , Administración por Inhalación , Adolescente , Agonistas Adrenérgicos beta/farmacología , Albuterol/farmacología , Albuterol/uso terapéutico , Análisis de Varianza , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Masculino , Registros Médicos , Estudios Multicéntricos como Asunto , Ápice del Flujo Espiratorio , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Xinafoato de Salmeterol , Factores de Tiempo
18.
Int J Aging Hum Dev ; 20(2): 93-102, 1984.
Artículo en Inglés | MEDLINE | ID: mdl-6526510

RESUMEN

While more and more institutions of higher education are offering cost-free continuing education programs to older men and women, the enrollment of this target population is quite low. This study was conducted to identify factors that would positively influence the decisions of individuals over sixty years of age to participate in such programs. Sixty-five white predominantly upper middle-class, highly educated (means = 16.92 years of schooling) women aged sixty years and over (means = 68.80) were given a questionnaire concerning attitudes toward continuing education. The majority (86%) indicated a high level of interest in taking geology, political science, world and art history, music, literature, and language courses. In addition, 85 percent preferred to participate in learning situations that included younger and older individuals; 58 percent reported interest in having a companion enroll with them; 48 percent preferred no specific learning environments (i.e., lecture, discussion, or workshop); and 75 percent reported that family members did not suggest that they enroll in continuing education classes. It is suggested that the high level of interest in taking courses offered by institutions of higher education displayed by the women surveyed is because of personal experience with university level education in young adulthood.


Asunto(s)
Anciano , Curriculum , Educación Continua , Humanos
19.
Sterile World ; 4(4): 9, 1982 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10261331
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA